Cardiorenal syndrome in decompensated heart failure: Prognostic and therapeutic implications View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-09

AUTHORS

Guido Boerrigter, John C. Burnett

ABSTRACT

Various lines of evidence implicate impaired renal function as an important prognostic indicator in patients with congestive heart failure (CHF). Conventional diuretics may aggravate renal dysfunction and can result in neurohumoral activation. Evolving new therapeutic strategies that enhance renal function include administration of B-type natriuretic peptide, adenosine and vasopressin antagonists, and ultrafiltration methods. Prospective studies are needed to evaluate whether these new renal-enhancing strategies will improve patient outcome in CHF. More... »

PAGES

113-120

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11897-004-0020-9

DOI

http://dx.doi.org/10.1007/s11897-004-0020-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041059064

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16036034


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diet", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemofiltration", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Life Style", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Syndrome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Boerrigter", 
        "givenName": "Guido", 
        "id": "sg:person.01021616027.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021616027.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burnett", 
        "givenName": "John C.", 
        "id": "sg:person.01001266776.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2004-09", 
    "datePublishedReg": "2004-09-01", 
    "description": "Various lines of evidence implicate impaired renal function as an important prognostic indicator in patients with congestive heart failure (CHF). Conventional diuretics may aggravate renal dysfunction and can result in neurohumoral activation. Evolving new therapeutic strategies that enhance renal function include administration of B-type natriuretic peptide, adenosine and vasopressin antagonists, and ultrafiltration methods. Prospective studies are needed to evaluate whether these new renal-enhancing strategies will improve patient outcome in CHF.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11897-004-0020-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2532198", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1033049", 
        "issn": [
          "1546-9530", 
          "1546-9549"
        ], 
        "name": "Current Heart Failure Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "1"
      }
    ], 
    "keywords": [
      "congestive heart failure", 
      "renal function", 
      "heart failure", 
      "decompensated heart failure", 
      "important prognostic indicator", 
      "type natriuretic peptide", 
      "new therapeutic strategies", 
      "neurohumoral activation", 
      "cardiorenal syndrome", 
      "renal dysfunction", 
      "conventional diuretics", 
      "prospective study", 
      "prognostic indicator", 
      "natriuretic peptide", 
      "vasopressin antagonist", 
      "patient outcomes", 
      "therapeutic strategies", 
      "therapeutic implications", 
      "evidence implicate", 
      "diuretics", 
      "patients", 
      "failure", 
      "dysfunction", 
      "syndrome", 
      "antagonist", 
      "administration", 
      "ultrafiltration method", 
      "outcomes", 
      "adenosine", 
      "activation", 
      "peptides", 
      "function", 
      "implicate", 
      "strategies", 
      "study", 
      "indicators", 
      "lines", 
      "implications", 
      "method"
    ], 
    "name": "Cardiorenal syndrome in decompensated heart failure: Prognostic and therapeutic implications", 
    "pagination": "113-120", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041059064"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11897-004-0020-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16036034"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11897-004-0020-9", 
      "https://app.dimensions.ai/details/publication/pub.1041059064"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_389.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11897-004-0020-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11897-004-0020-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11897-004-0020-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11897-004-0020-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11897-004-0020-9'


 

This table displays all metadata directly associated to this object as RDF triples.

185 TRIPLES      21 PREDICATES      85 URIs      77 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11897-004-0020-9 schema:about N04c9f5be025c4b09942442443a7932ff
2 N06b587b0c58746a9846ee6ac8542bf54
3 N0a7a0133db7c4f2caaa1ce11788be3dc
4 N0daa4be947724fedb88a3aafb1bd597b
5 N158a2eec99fe4eb69cae37e72f6133ce
6 N336f8e7e775546f9a2151e5add2e7144
7 N54e18ebcaf804bddacc7fd4eac724ff7
8 N5d3de2cac76042d2b087d96c7eed65fe
9 N66efd8af2fc5464b914aac52b7dfb7c0
10 N7bbd5de9f4f84590a76b4ec7abeb461b
11 N9d913d3d25d2479497a789f5e05b97e0
12 Nae1af5382dbe49228046ab6c07440690
13 Nc3ed94826f4e4158a4934a5a5d32d6f1
14 Nc435c2e3a2ee4ce28aae621350b5f159
15 Ncf843f0f42284dd2b3a7d829137944e3
16 Nd54251c1a4624c7e97d77b3459dfe479
17 Ne1fa4157058d4ccd837bcbc6bf3e4d52
18 Nf79ea0d3145a4264845a4a40702cfdfd
19 Nf9cbb47414ee4bd8bd3b512eb76f96b2
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author N1797a8543b83482caca60898ce81c573
23 schema:datePublished 2004-09
24 schema:datePublishedReg 2004-09-01
25 schema:description Various lines of evidence implicate impaired renal function as an important prognostic indicator in patients with congestive heart failure (CHF). Conventional diuretics may aggravate renal dysfunction and can result in neurohumoral activation. Evolving new therapeutic strategies that enhance renal function include administration of B-type natriuretic peptide, adenosine and vasopressin antagonists, and ultrafiltration methods. Prospective studies are needed to evaluate whether these new renal-enhancing strategies will improve patient outcome in CHF.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N50c9efa063ca4c05a1b60e0bc00d868e
30 N84fdc07a3bdc464fbba657bbfd0e846b
31 sg:journal.1033049
32 schema:keywords activation
33 adenosine
34 administration
35 antagonist
36 cardiorenal syndrome
37 congestive heart failure
38 conventional diuretics
39 decompensated heart failure
40 diuretics
41 dysfunction
42 evidence implicate
43 failure
44 function
45 heart failure
46 implicate
47 implications
48 important prognostic indicator
49 indicators
50 lines
51 method
52 natriuretic peptide
53 neurohumoral activation
54 new therapeutic strategies
55 outcomes
56 patient outcomes
57 patients
58 peptides
59 prognostic indicator
60 prospective study
61 renal dysfunction
62 renal function
63 strategies
64 study
65 syndrome
66 therapeutic implications
67 therapeutic strategies
68 type natriuretic peptide
69 ultrafiltration method
70 vasopressin antagonist
71 schema:name Cardiorenal syndrome in decompensated heart failure: Prognostic and therapeutic implications
72 schema:pagination 113-120
73 schema:productId N693239daa0904e88a39f5a8be9da032f
74 Ncd6b3f0c4d7b4637a84e653494956a2d
75 Ne69369e6cbe04f35a678b6b98b64c218
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041059064
77 https://doi.org/10.1007/s11897-004-0020-9
78 schema:sdDatePublished 2022-05-20T07:22
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher N7ed804fbf3314b32a9a0605b24ca5bfe
81 schema:url https://doi.org/10.1007/s11897-004-0020-9
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N04c9f5be025c4b09942442443a7932ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Male
87 rdf:type schema:DefinedTerm
88 N06ae5cf82dfc4bd8857a8fdb20f9493d rdf:first sg:person.01001266776.01
89 rdf:rest rdf:nil
90 N06b587b0c58746a9846ee6ac8542bf54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Kidney Function Tests
92 rdf:type schema:DefinedTerm
93 N0a7a0133db7c4f2caaa1ce11788be3dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Diet
95 rdf:type schema:DefinedTerm
96 N0daa4be947724fedb88a3aafb1bd597b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Hemofiltration
98 rdf:type schema:DefinedTerm
99 N158a2eec99fe4eb69cae37e72f6133ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Prognosis
101 rdf:type schema:DefinedTerm
102 N1797a8543b83482caca60898ce81c573 rdf:first sg:person.01021616027.74
103 rdf:rest N06ae5cf82dfc4bd8857a8fdb20f9493d
104 N336f8e7e775546f9a2151e5add2e7144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Severity of Illness Index
106 rdf:type schema:DefinedTerm
107 N50c9efa063ca4c05a1b60e0bc00d868e schema:volumeNumber 1
108 rdf:type schema:PublicationVolume
109 N54e18ebcaf804bddacc7fd4eac724ff7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Diuretics
111 rdf:type schema:DefinedTerm
112 N5d3de2cac76042d2b087d96c7eed65fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Female
114 rdf:type schema:DefinedTerm
115 N66efd8af2fc5464b914aac52b7dfb7c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Heart Failure
117 rdf:type schema:DefinedTerm
118 N693239daa0904e88a39f5a8be9da032f schema:name dimensions_id
119 schema:value pub.1041059064
120 rdf:type schema:PropertyValue
121 N7bbd5de9f4f84590a76b4ec7abeb461b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Drug Therapy, Combination
123 rdf:type schema:DefinedTerm
124 N7ed804fbf3314b32a9a0605b24ca5bfe schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N84fdc07a3bdc464fbba657bbfd0e846b schema:issueNumber 3
127 rdf:type schema:PublicationIssue
128 N9d913d3d25d2479497a789f5e05b97e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Biomarkers
130 rdf:type schema:DefinedTerm
131 Nae1af5382dbe49228046ab6c07440690 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Comorbidity
133 rdf:type schema:DefinedTerm
134 Nc3ed94826f4e4158a4934a5a5d32d6f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Kidney Diseases
136 rdf:type schema:DefinedTerm
137 Nc435c2e3a2ee4ce28aae621350b5f159 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Disease Progression
139 rdf:type schema:DefinedTerm
140 Ncd6b3f0c4d7b4637a84e653494956a2d schema:name pubmed_id
141 schema:value 16036034
142 rdf:type schema:PropertyValue
143 Ncf843f0f42284dd2b3a7d829137944e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Combined Modality Therapy
145 rdf:type schema:DefinedTerm
146 Nd54251c1a4624c7e97d77b3459dfe479 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Syndrome
148 rdf:type schema:DefinedTerm
149 Ne1fa4157058d4ccd837bcbc6bf3e4d52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Humans
151 rdf:type schema:DefinedTerm
152 Ne69369e6cbe04f35a678b6b98b64c218 schema:name doi
153 schema:value 10.1007/s11897-004-0020-9
154 rdf:type schema:PropertyValue
155 Nf79ea0d3145a4264845a4a40702cfdfd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Survival Rate
157 rdf:type schema:DefinedTerm
158 Nf9cbb47414ee4bd8bd3b512eb76f96b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Life Style
160 rdf:type schema:DefinedTerm
161 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
162 schema:name Medical and Health Sciences
163 rdf:type schema:DefinedTerm
164 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
165 schema:name Cardiorespiratory Medicine and Haematology
166 rdf:type schema:DefinedTerm
167 sg:grant.2532198 http://pending.schema.org/fundedItem sg:pub.10.1007/s11897-004-0020-9
168 rdf:type schema:MonetaryGrant
169 sg:journal.1033049 schema:issn 1546-9530
170 1546-9549
171 schema:name Current Heart Failure Reports
172 schema:publisher Springer Nature
173 rdf:type schema:Periodical
174 sg:person.01001266776.01 schema:affiliation grid-institutes:grid.66875.3a
175 schema:familyName Burnett
176 schema:givenName John C.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01
178 rdf:type schema:Person
179 sg:person.01021616027.74 schema:familyName Boerrigter
180 schema:givenName Guido
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021616027.74
182 rdf:type schema:Person
183 grid-institutes:grid.66875.3a schema:alternateName Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA
184 schema:name Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA
185 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...